Ibrutinib combination regimens for CLL from ASH 2017
ZUMA-1 trial: FDA approval and follow-up of CAR T-cell product axicabtagene ciloleucel
Why use model systems for multiple myeloma research?
Enrique Ocio et al.
MRD studies in ALL and AML
Role of nurses in fungal disease management